Preterm Birth and PROM Testing Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Preterm Birth and PROM Testing Market covers analysis By Test Type (Preterm Birth Test, PROM tests); End User (Hospitals, Diagnostic Laboratories), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00005197
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION


Preterm Birth and PROM (Premature rupture of membranes) is the rupture of fetal membranes that occurs before 37 weeks' gestation. This may be caused by natural weakening of the membrane or from the forces of the contraction or due to an infection in the uterus.

MARKET DYNAMICS


The Preterm Birth and PROM Testing market is anticipated to grow in the forecast, owing to the factors such as rising number of preterm births, increasing average woman being pregnant with diseases like diabetes and high blood pressure, growing demand for point-of-care testing devices and rise in demand for cost effective diagnostic tests. Nevertheless, lack of awareness about new technologies and use of alternative diagnostic such as transvaginal scan etc. are expected to restrict the market growth during the forecast period.

MARKET SCOPE


The "Global Preterm Birth and PROM Testing Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Preterm Birth and PROM Testing market with detailed market segmentation by Test Type, end user and geography. The global Preterm Birth and PROM Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Preterm Birth and PROM Testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION


The global Preterm Birth and PROM Testing market is segmented on the basis of Test Type and End User. Based on Test type the market is segmented into Preterm Birth Test and PROM tests. Preterm Birth tests is further sub segmented into Pelvic Exam, Ultrasound, Uterine Monitoring, Biomarkers. PROM test is further sub segmented into Nitrazine Test, Ferning Test, Pooling, Ultrasound, Fetal Fibronectin Test, Biomarkers and Others. Based on End User the market is segmented into Hospitals, Diagnostic Laboratories.
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Preterm Birth and PROM Testing market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Preterm Birth and PROM Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Preterm Birth and PROM Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Preterm Birth and PROM Testing market in these regions.

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

MARKET PLAYERS


The reports cover key developments in the Preterm Birth and PROM Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Preterm Birth and PROM Testing market are anticipated to lucrative growth opportunities in the future with the rising demand for Preterm Birth and PROM Testing market in the global market. Below mentioned is the list of few companies engaged in the Preterm Birth and PROM Testing market.

The report also includes the profiles of Preterm Birth and PROM Testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • QIAGEN
  • Hologic, Inc
  • Medix Biochemica
  • Biosynex
  • Abbott Laboratories
  • Clinical Innovations, LLC
  • Sera Prognostics, Inc
  • The Cooper Companies, Inc
  • NX Prenatal, Inc
  • IQ Products
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Preterm Birth and PROM Testing Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Test Type
  • Preterm Birth Test
  • PROM tests
By End User
  • Hospitals
  • Diagnostic Laboratories
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • QIAGEN
  • Hologic, Inc
  • Medix Biochemica
  • Biosynex
  • Abbott Laboratories
  • Clinical Innovations, LLC
  • Sera Prognostics, Inc
  • The Cooper Companies, Inc
  • NX Prenatal, Inc
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    - QIAGEN
    - Hologic, Inc
    - Medix Biochemica
    - Biosynex
    - Abbott Laboratories
    - Clinical Innovations, LLC
    - Sera Prognostics, Inc
    - The Cooper Companies, Inc
    - NX Prenatal, Inc
    - IQ Products

    Buy Now